Background: Men who have sex with men (MSM) are selected for Human Papillomavirus (HPV) vaccination due to their higher risk of genital warts and anal cancer. Aim: To examine HPV vaccine acceptability amongst MSM in the UK. Methods: Using Facebook advertisements, MSM were recruited for an online survey measuring motivations for HPV vaccination. Logistic regression was performed to identify predictors of HPV vaccine acceptability at baseline, after receiving information about HPV vaccination, and four weeks later. Results: Out of 1508 MSM (median age = 22, range: 15–63) 19% knew about HPV. While only 55% of MSM would be willing to ask for the HPV vaccine, 89% would accept it if offered by a healthcare professional (HCP). Access t...
Background Targeted human papillomavirus (HPV) vaccine could prevent HPV-related cancers and genital...
Background Female-only HPV vaccination will fail to protect MSM against HPV and its sequelae i.e. g...
Background: female-only HPV vaccination will fail to protect MSM against HPV and its sequelae i.e. ...
Background: Men who have sex with men (MSM) are recommended the Human Papillomavirus (HPV) vaccinati...
Background Men who have sex with men (MSM) are recommended the Human Papillomavirus (HPV) vaccinati...
Background Men who have sex with men (MSM) are recommended the Human Papillomavirus (HPV) vaccinati...
Background: Men who have sex with men (MSM) are recommended the Human Papillomavirus (HPV) vaccinati...
Background: Men who have sex with men (MSM) are recommended the Human Papillomavirus (HPV) vaccinati...
Objectives: Men who have sex with men (MSM) are at risk of genital warts and anal cancer due to huma...
Human Papillomavirus (HPV) vaccine could prevent HPV-related cancers and genital warts among MSM. Co...
Objectives: Men who have sex with men (MSM) are at risk of genital warts and anal cancer due to huma...
Objectives Men who have sex with men (MSM) are at risk of genital warts and anal cancer due to human...
Objectives: Men-who-have-sex-with-men (MSM) are at greater risk for HPV-associated cancers. Since 20...
Background/introduction Men who have sex with men (MSM) are at risk of HPV-associated genital warts ...
Background Targeted human papillomavirus (HPV) vaccine could prevent HPV-related cancers and genital...
Background Targeted human papillomavirus (HPV) vaccine could prevent HPV-related cancers and genital...
Background Female-only HPV vaccination will fail to protect MSM against HPV and its sequelae i.e. g...
Background: female-only HPV vaccination will fail to protect MSM against HPV and its sequelae i.e. ...
Background: Men who have sex with men (MSM) are recommended the Human Papillomavirus (HPV) vaccinati...
Background Men who have sex with men (MSM) are recommended the Human Papillomavirus (HPV) vaccinati...
Background Men who have sex with men (MSM) are recommended the Human Papillomavirus (HPV) vaccinati...
Background: Men who have sex with men (MSM) are recommended the Human Papillomavirus (HPV) vaccinati...
Background: Men who have sex with men (MSM) are recommended the Human Papillomavirus (HPV) vaccinati...
Objectives: Men who have sex with men (MSM) are at risk of genital warts and anal cancer due to huma...
Human Papillomavirus (HPV) vaccine could prevent HPV-related cancers and genital warts among MSM. Co...
Objectives: Men who have sex with men (MSM) are at risk of genital warts and anal cancer due to huma...
Objectives Men who have sex with men (MSM) are at risk of genital warts and anal cancer due to human...
Objectives: Men-who-have-sex-with-men (MSM) are at greater risk for HPV-associated cancers. Since 20...
Background/introduction Men who have sex with men (MSM) are at risk of HPV-associated genital warts ...
Background Targeted human papillomavirus (HPV) vaccine could prevent HPV-related cancers and genital...
Background Targeted human papillomavirus (HPV) vaccine could prevent HPV-related cancers and genital...
Background Female-only HPV vaccination will fail to protect MSM against HPV and its sequelae i.e. g...
Background: female-only HPV vaccination will fail to protect MSM against HPV and its sequelae i.e. ...